ArticleBreast (Edinburgh, Scotland)2020

HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab.

Shuai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.